Icon Advisers Inc. Co. Takes $429,000 Position in Hill-Rom Holdings Inc (NYSE:HRC)

Icon Advisers Inc. Co. purchased a new position in Hill-Rom Holdings Inc (NYSE:HRC) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,800 shares of the medical technology company’s stock, valued at approximately $429,000.

Other institutional investors have also recently bought and sold shares of the company. Seven Eight Capital LP bought a new position in Hill-Rom in the 2nd quarter worth $127,000. Acrospire Investment Management LLC increased its holdings in shares of Hill-Rom by 43.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock worth $158,000 after purchasing an additional 600 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Hill-Rom by 10.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock worth $175,000 after purchasing an additional 204 shares during the period. Citigroup Inc. increased its holdings in shares of Hill-Rom by 21.1% during the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock worth $198,000 after purchasing an additional 433 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its holdings in shares of Hill-Rom by 101.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,720 shares of the medical technology company’s stock worth $204,000 after purchasing an additional 1,367 shares during the period. 82.35% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have commented on HRC. ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a research report on Thursday, November 16th. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a research report on Friday, October 27th. KeyCorp reissued a “buy” rating and set a $82.00 price target on shares of Hill-Rom in a research note on Tuesday, October 17th. Stifel Nicolaus boosted their price target on shares of Hill-Rom from $84.00 to $85.00 and gave the stock a “buy” rating in a research note on Monday, November 6th. Finally, Needham & Company LLC lowered their target price on shares of Hill-Rom from $93.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 6th. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $89.57.

Hill-Rom Holdings Inc (NYSE:HRC) opened at $82.84 on Tuesday. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. Hill-Rom Holdings Inc has a 1 year low of $53.80 and a 1 year high of $85.25. The company has a market cap of $5,543.44, a PE ratio of 21.82, a P/E/G ratio of 1.79 and a beta of 1.19.

Hill-Rom (NYSE:HRC) last released its earnings results on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.27 by $0.05. Hill-Rom had a net margin of 4.87% and a return on equity of 20.27%. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. During the same period last year, the firm earned $1.18 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. analysts anticipate that Hill-Rom Holdings Inc will post 4.26 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be given a dividend of $0.18 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.72 annualized dividend and a yield of 0.87%. Hill-Rom’s dividend payout ratio is presently 36.18%.

In other news, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,293,993.48. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Icon Advisers Inc. Co. Takes $429,000 Position in Hill-Rom Holdings Inc (NYSE:HRC)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/05/icon-advisers-inc-co-takes-position-in-hill-rom-holdings-inc-hrc.html.

Hill-Rom Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply